
Rapid plasma genotyping technique allow for more rapid test results in non-small cell lung cancer.

Rapid plasma genotyping technique allow for more rapid test results in non-small cell lung cancer.

Mevalonate pathway associated with cell-signaling protein that promotes breast cancer development.

In some cases, Raynaud's Disease can cause blood circulation to fingers and toes to permanently diminish, leading to deformities.

Study finds 12 total drug classes that can cause Raynaud’s disease.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

Recent advances and updates in oncology and cancer drug development.

Gastrointestinal stromal tumors result in higher mortality than originally estimated.

TZD-based medicines effectively improve glucose uptake.

Advanced T cell receptor sequencing may predict efficacy of immunotherapy in brain cancer treatment.

Top news of the day from across the health care landscape.

Study finds fewer exchange health plans are placing specialty drugs on the highest tier.

Top news from across the health care landscape.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

RO 48-8971 may inhibit the growth of and kill prostate cancer cells.

Bisphenol A is found in numerous plastic and resin household products.

Blocking the recruitment of blood vessels suppresses small cell lung cancer tumor growth.

Consuming 2.5 servings of coffee per day found to decrease colorectal cancer development by up to 50%.

Top news of the day from across the health care landscape.

Afatinib (Gilotrif) shows significant improvements in overall survival and disease progression.

New technique offers sustained release of antibodies directly to skin cancer tumor.

Afatinib (Gilotrif) shows significant improvements in overall survival and disease progression.

Recent advances and updates in oncology and cancer drug development.

Sulindac and erlotinib effectively reduced the total duodenal polyps in patients with familial adenomatous polyposis.

Sugary drinks found to triple the risk of developing prostate cancer.

A new study shows that genes can become sensitive to crizotinib after the introduction of ponatinib.

Top news of the day from across the health care landscape.

Dietary intake of methionine and tryptophan may slow brain cancer tumor progression.

Single-cell method identifies core stem cells that cause leukemia within a tumor.

Ruptured cancerous cells are able to repair themselves to prevent cell death.